PERSONALIZED HYPOTHESIS TESTS FOR DETECTING MEDICATION RESPONSE IN PARKINSON DISEASE PATIENTS USING iPHONE SENSOR DATA
Open accessAbstract
We propose hypothesis tests for detecting dopaminergic medication response in Parkinson disease patients, using longitudinal sensor data collected by smartphones. The processed data is composed of multiple features extracted from active tapping tasks performed by the participant on a daily basis, before and after medication, over several months. Each extracted feature corresponds to a time series of measurements annotated according to whether the measurement was taken before or after the patient has taken his/her medication. Even though the data is longitudinal in nature, we show that simple hypothesis tests for detecting medication response, which ignore the serial correlation structure of the data, are still statistically valid, showing type I error rates at the nominal level. We propose two distinct personalized testing approaches. In the first, we combine multiple feature-specific tests into a single union-intersection test. In the second, we construct personalized classifiers of the before/after medication labels using all the extracted features of a given participant, and test the null hypothesis that the area under the receiver operating characteristic curve of the classifier is equal to 1/2. We compare the statistical power of the personalized classifier tests and personalized union-intersection tests in a simulation study, and illustrate the performance of the proposed tests using data from mPower Parkinsons disease study, recently launched as part of Apples Research…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Wearable sensor-based, quantitative, objective, and easy-to-use systems for quantifying PD signs for large numbers of participants over extended durations have been developed.
“More recently, 'wearable', sensor-based, quantitative, objective, and easy-to-use systems for quantifying PD signs for large numbers of participants over extended durations have been developed.”
From Machine learning for large‐scale wearable sensor data in Parkinson's disease: Concepts, promises, pitfalls, and futures (2016) · cites this paper as [7]
In the US-wide mPower iPhone-based study of PD, touchscreen tapping sensor data from 57 PD participants was analyzed using various machine learning algorithms, and individualized medication responsiveness was quantifiable using this tapping data.
“Here, touchscreen tapping sensor data from 57 PD participants was analyzed using various machine learning algorithms. Individualized medication responsiveness was also quantifiable using this tapping data.”
From Machine learning for large‐scale wearable sensor data in Parkinson's disease: Concepts, promises, pitfalls, and futures (2016) · cites this paper as [7]
The transformation of raw data into a form that accurately reflects PD disease severity and progression requires continued research.
“The transformation of raw data into a form that accurately reflects PD disease severity and progression requires continued research, even as large-scale studies such as Fox Insight 28 , Smartphone-PD 5 and mPower 7 continue to amass data.”
From Machine learning for large‐scale wearable sensor data in Parkinson's disease: Concepts, promises, pitfalls, and futures (2016) · cites this paper as [7]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 2 · Cited by 33
- Authors
- CHAIBUB NETO, E., BOT, B. M., PERUMAL, T., OMBERG, L., GUINNEY, J., KELLEN, M., KLEIN, A., FRIEND, S. H., & TRISTER, A. D.
- Affiliations
- Sage Bionetworks, 1100 Fairview Avenue North, Seattle, Washington 98109, USA
- Sage Bionetworks (US)
- ORCID
- Venue
- Biocomputing 2016
- Publisher
- WORLD SCIENTIFIC
- Published
- 2015-11-18
- Volume
- 21
- Pages
- 273-84
- OpenAlex
- W2328885510
- Cited by
- 33
- References
- 2
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 4
- FWCI
- 9.86
- Type
- conference paper
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Pacific Symposium on Biocomputing (PSB) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Advanced Statistical Process Monitoring
- Keywords
- Parkinson's disease, smartphone sensor data, hypothesis testing, union-intersection tests, longitudinal data, serial correlation, ResearchKit, statistical power
- MeSH terms
- Algorithms, Computer Simulation, Data Interpretation, Statistical, Humans, Parkinson Disease, Models, Statistical, Dopamine Agents, Drug Monitoring, Computational Biology, Cell Phone, Precision Medicine, Remote Sensing Technology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review